News Daily News Un Estudio Histología-IVUS Revela que el Tratamiento con Estatinas Altera la Composición de las Placas Coronarias Michael O'Riordan April 14, 2016
News Daily News Statin Therapy Alters Composition of Coronary Plaques, Virtual Histology-IVUS Study Shows Michael O'Riordan April 14, 2016
News Daily News Another CV Outcomes Trial Testing Weight-Loss Drug Contrave Terminated Early Michael O'Riordan April 14, 2016
News Daily News USPSTF Tightens Up Primary-Prevention Recommendations, Saying Aspirin Should Be Used Only in High-Risk Individuals Michael O'Riordan April 12, 2016
News Daily News El USPSTF Refuerza las Recomendaciones en materia de Prevención Primaria al asegurar que la Aspirina Solo Debería de Emplearse en Sujetos de Riesgo Alto Michael O'Riordan April 12, 2016
News Daily News FDA Approves Impella Left-Ventricular Heart Pumps for Cardiogenic Shock Michael O'Riordan April 08, 2016
News Conference News ACC 2016 Valve Hemodynamic Deterioration Post-TAVR Is Rare, Not Linked With Adverse Cardiovascular Outcomes Michael O'Riordan April 07, 2016
News Conference News ACC 2016 Older Men With Existing Coronary Disease at Highest Risk of Dying During a Triathlon Michael O'Riordan April 06, 2016
Presentation Three-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter AVR Presenter: G. Michael Deeb April 06, 2016
News Conference News ACC 2016 Vagus Nerve Stimulation Fails to Improve Clinical Outcomes in Chronic Heart Failure Todd Neale April 05, 2016
News Conference News ACC 2016 STEPATHLON: A Mobile-Based Exercise Program Increased Physical Activity and Promoted Weight Loss Michael O'Riordan April 04, 2016
News Conference News ACC 2016 ‘Enhanced’ Multicellular Stem Cell Therapy Improves Clinical Outcomes in Heart Failure: ixCELL-DCM Study Michael O'Riordan April 04, 2016
News Conference News ACC 2016 Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients L.A. McKeown April 04, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016
News Daily News ACC actualiza las recomendaciones para bajar el colesterol LBD, abriendo un espacio para el uso de Ezetimibe y de los inhibidores de PCSK9 Michael O'Riordan April 02, 2016